159 related articles for article (PubMed ID: 11805006)
1. Serum paraoxonase activity: a new additional test for the improved evaluation of chronic liver damage.
Ferré N; Camps J; Prats E; Vilella E; Paul A; Figuera L; Joven J
Clin Chem; 2002 Feb; 48(2):261-8. PubMed ID: 11805006
[TBL] [Abstract][Full Text] [Related]
2. Baseline and salt-stimulated paraoxonase and arylesterase activities in patients with chronic liver disease: relation to disease severity.
Keskin M; Dolar E; Dirican M; Kiyici M; Yilmaz Y; Gurel S; Nak SG; Erdinc S; Gulten M
Intern Med J; 2009 Apr; 39(4):243-8. PubMed ID: 19402863
[TBL] [Abstract][Full Text] [Related]
3. Serum Basal Paraoxonase 1 Activity as an Additional Liver Function Test for the Evaluation of Patients with Chronic Hepatitis.
Pyati AK; Halappa CK; Pyati SA; Nagaraj ; Wali V
J Clin Diagn Res; 2015 Nov; 9(11):BC12-5. PubMed ID: 26674516
[TBL] [Abstract][Full Text] [Related]
4. Serum lactonase and arylesterase activities in alcoholic hepatitis and hepatitis B.
Mogarekar MR; Talekar SJ
Indian J Gastroenterol; 2013 Sep; 32(5):307-10. PubMed ID: 23700138
[TBL] [Abstract][Full Text] [Related]
5. Paraoxonase and susceptibility to organophosphorus poisoning in farmers dipping sheep.
Mackness B; Durrington P; Povey A; Thomson S; Dippnall M; Mackness M; Smith T; Cherry N
Pharmacogenetics; 2003 Feb; 13(2):81-8. PubMed ID: 12563177
[TBL] [Abstract][Full Text] [Related]
6. Serum arylesterase and paraoxonase activity in patients with chronic hepatitis.
Kilic SS; Aydin S; Kilic N; Erman F; Aydin S; Celik I
World J Gastroenterol; 2005 Dec; 11(46):7351-4. PubMed ID: 16437641
[TBL] [Abstract][Full Text] [Related]
7. Serum paraoxonase 1 activity status in patients with liver disorders.
Kedage V; Muttigi MS; Shetty MS; Suvarna R; Rao SS; Joshi C; Prakash M
Saudi J Gastroenterol; 2010; 16(2):79-83. PubMed ID: 20339175
[TBL] [Abstract][Full Text] [Related]
8. HDL3-related decreased serum paraoxonase (PON) activity in uremic patients: comparison with the PON1 allele polymorphism.
Schiavon R; Battaglia P; De Fanti E; Fasolin A; Biasioli S; Targa L; Guidi G
Clin Chim Acta; 2002 Oct; 324(1-2):39-44. PubMed ID: 12204423
[TBL] [Abstract][Full Text] [Related]
9. Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon.
Mackness B; Mackness MI; Arrol S; Turkie W; Durrington PN
Br J Pharmacol; 1997 Sep; 122(2):265-8. PubMed ID: 9313934
[TBL] [Abstract][Full Text] [Related]
10. Determination of paraoxonase (PON1) status requires more than genotyping.
Richter RJ; Furlong CE
Pharmacogenetics; 1999 Dec; 9(6):745-53. PubMed ID: 10634137
[TBL] [Abstract][Full Text] [Related]
11. Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus.
Mackness B; Mackness MI; Arrol S; Turkie W; Julier K; Abuasha B; Miller JE; Boulton AJ; Durrington PN
Atherosclerosis; 1998 Aug; 139(2):341-9. PubMed ID: 9712341
[TBL] [Abstract][Full Text] [Related]
12. New paraoxonase 1 polymorphism I102V and the risk of prostate cancer in Finnish men.
Marchesani M; Hakkarainen A; Tuomainen TP; Kaikkonen J; Pukkala E; Uimari P; Seppälä E; Matikainen M; Kallioniemi OP; Schleutker J; Lehtimäki T; Salonen JT
J Natl Cancer Inst; 2003 Jun; 95(11):812-8. PubMed ID: 12783936
[TBL] [Abstract][Full Text] [Related]
13. Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position - 107, implicating the Sp1 transcription factor.
Deakin S; Leviev I; Brulhart-Meynet MC; James RW
Biochem J; 2003 Jun; 372(Pt 2):643-9. PubMed ID: 12639220
[TBL] [Abstract][Full Text] [Related]
14. Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseases.
Ferré N; Marsillach J; Camps J; Mackness B; Mackness M; Riu F; Coll B; Tous M; Joven J
J Hepatol; 2006 Jul; 45(1):51-9. PubMed ID: 16510204
[TBL] [Abstract][Full Text] [Related]
15. Serum paraoxonase after myocardial infarction.
Ayub A; Mackness MI; Arrol S; Mackness B; Patel J; Durrington PN
Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):330-5. PubMed ID: 9974415
[TBL] [Abstract][Full Text] [Related]
16. Dietary modifications and gene polymorphisms alter serum paraoxonase activity in healthy women.
Rantala M; Silaste ML; Tuominen A; Kaikkonen J; Salonen JT; Alfthan G; Aro A; Kesäniemi YA
J Nutr; 2002 Oct; 132(10):3012-7. PubMed ID: 12368388
[TBL] [Abstract][Full Text] [Related]
17. Serum paraoxonase-1 as biomarker for improved diagnosis of fatty liver in dairy cows.
Farid AS; Honkawa K; Fath EM; Nonaka N; Horii Y
BMC Vet Res; 2013 Apr; 9():73. PubMed ID: 23578174
[TBL] [Abstract][Full Text] [Related]
18. Serum paraoxonase and arylesterase activities in hemodialysis patients.
Itahara T; Suehiro T; Ikeda Y; Inoue M; Nakamura T; Kumon Y; Kawada M; Hashimoto K
J Atheroscler Thromb; 2000; 7(3):152-8. PubMed ID: 11480456
[TBL] [Abstract][Full Text] [Related]
19. Monitoring the level of serum paraoxonase 1 activity in liver transplantation patients.
Xu GY; Lv GC; Chen Y; Hua YC; Zhu SM; Yang YD
Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):178-81. PubMed ID: 15908311
[TBL] [Abstract][Full Text] [Related]
20. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy.
Mackness B; Durrington PN; Abuashia B; Boulton AJ; Mackness MI
Clin Sci (Lond); 2000 Mar; 98(3):355-63. PubMed ID: 10677395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
